Timothy Trysla

Timothy Trysla

Alston & Bird

Contact

Readers' Choice Awards

Healthcare
Healthcare
Healthcare
View Bio
RSS

Latest Posts › Coronavirus/COVID-19

Share:

Health Care Week in Review: House Committee on Oversight and Accountability Held a Hearing on PBMs; HHS Reorganizes Technology,...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/29/2024  /  Biosimilars , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Electronic Protected Health Information (ePHI) , Federal Food Drug and Cosmetic Act (FFDCA) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare , Healthcare Facilities , Medical Devices , National Institute of Health (NIH) , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , Prescription Drugs , Public Health

Health Care Week in Review: House Held a Markup of 23 Bills; Senators Announced a Proposal on Primary Care Payment Reform

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/20/2024  /  Centers for Disease Control and Prevention (CDC) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Federal Food Drug and Cosmetic Act (FFDCA) , Food and Drug Administration (FDA) , Health Care Providers , Life Sciences , Medical Devices , National Institute of Health (NIH) , Pharmaceutical Industry , Prescription Drugs , Public Health

Health Care Week in Review: CMS Finalizes Medicaid DSH Rule and House Launches Bipartisan AI Task Force

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/26/2024  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Clinical Trials , Coronavirus/COVID-19 , Digital Health , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Hospitals , Medicaid , Medical Devices , Pharmaceutical Industry , Popular , Public Health Emergency

Health Care Week In Review: HHS Selects the First 10 Drugs for Medicare Drug Price Negotiation

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

9/6/2023  /  AHRQ , Biologics , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Long Term Care Facilities , Medicare , National Institute of Health (NIH) , Pharmaceutical Industry , Popular , Prescription Drugs , Skilled Nursing Facility

Health Care Week In Review: CMS Releases SNF and IPPS Final Rules

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/7/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Medicare , Skilled Nursing Facility

Health Care Week in Review: Emerging Technology Coverage Pathway, Long COVID Advisory

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

6/26/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , National Institute of Health (NIH) , Pharmaceutical Industry , Popular , SAMHSA

Health Care Week in Review: HHS Coverage Flexibilities and MedPAC/MACPAC Reports

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

6/19/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , DEA , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Popular , Prescription Drugs , Telehealth , Telemedicine

Health Care Week In Review: Fifth Circuit Review of ACA Requirement and HRSA Funds Health Centers

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/22/2023  /  Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Mental Health , Nursing Homes , Popular , Public Health Emergency

Health Care Week In Review: COVID-19 PHE Expires, DEA Issues Final Rule

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/15/2023  /  Biologics , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , Coronavirus/COVID-19 , DEA , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Popular , Prescription Drugs , Public Health Emergency , Telehealth , Telemedicine

Health Care Week in Review: Senate Votes to End COVID-19 National Emergency, CMS Releases Rate Notice

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

4/3/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , Medicare , Popular , Public Health Emergency

Health Care Week in Review: CMS Issues Prior Authorization Proposed Rule

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

12/12/2022  /  Affordable Care Act , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Food and Drug Administration (FDA) , Health Care Providers , Health Insurance , Medicaid , Medicare , Pharmaceutical Industry , Popular , Prescription Drugs , Vaccinations

Health Care Week in Review: HHS Extended the COVID-19 PHE for an Additional 90 Days

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

10/18/2022  /  Centers for Disease Control and Prevention (CDC) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Executive Orders , Food and Drug Administration (FDA) , Health Care Providers , Mental Health , Prescription Drugs , Telehealth

Health Care Week in Review: HHS Declared a Public Health Emergency (PHE) for Puerto Rico Due to the Flooding

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

9/27/2022  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Medicaid , Medical Devices , Nursing Homes , OIG , Popular , Public Health Emergency

Health Care Week in Review: CMS Issues a Request for Information to Gather Public Input on Accessing Healthcare and Related...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

9/13/2022  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Prescription Drugs , Public Health Emergency , Vaccinations

Health Care Week in Review: HHS Issued Proposed Rule to Affirm Protections Against Discrimination

Below is Alston & Bird's Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/1/2022  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , Vaccinations

Health Care Week in Review: HHS Announced the Distribution of $49 Million to Organizations

Below is Alston & Bird's Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/25/2022  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , Prescription Drugs , Vaccinations

Health Care Week in Review: CMS Released CY 2023 OPPS Proposed Rule

Below is Alston & Bird's Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/18/2022  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Health Care Providers , Long Term Care Facilities , Medicaid , Medicare , Popular , Prescription Drugs

Health Care Week in Review: CMS Issued ESRD Proposed Rule

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

6/27/2022  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , National Institute of Health (NIH) , SAMHSA , Supply Chain

Health Care Week in Review: HHS Issued Guidance on HIPAA Compliance with Audio-Only Telehealth

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

6/20/2022  /  Centers for Disease Control and Prevention (CDC) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Health Insurance Portability and Accountability Act (HIPAA) , National Institute of Health (NIH) , OIG , Provider Relief Fund , Telehealth , Telemedicine

Health Care Week in Review: The Medicare Trustees Released a Report Projecting Medicare Would Remain Solvent Until 2028

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

6/6/2022  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medical Devices , Medicare

Health Care Week in Review: HHS Issued an Advisory Highlighting the Need to Address the Health Worker Burnout Crisis

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/31/2022  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Workers , Medicaid , Medicare , National Institute of Health (NIH) , Popular

Alston & Bird Health Care Week in Review - May 2022 #3

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/23/2022  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Medicaid , Medicare , Popular , Provider Relief Fund

Alston & Bird Health Care Week in Review - May 2022 #2

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/16/2022  /  American Rescue Plan Act of 2021 , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , HRSA , Medicaid , Medicare , Popular

Alston & Bird Health Care Week in Review - May 2022 #1

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/9/2022  /  Centers for Disease Control and Prevention (CDC) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Investigational New Drug Application (IND) , Medicaid , Medical Devices , Medicare , Pharmaceutical Industry , Popular , Prescription Drugs , Telehealth , Vaccinations

Alston & Bird Health Care Week in Review - April 2022 #5

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/2/2022  /  Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Clinical Trials , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicare , National Institute of Health (NIH) , Prescription Drugs
119 Results
 / 
View per page
Page: of 5
Next »

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide